ImmuneWatch DESIGN
Use machine learning to find epitopes or antigens for your vaccine.
Looking for potent antigens and epitopes to design your vaccine?
Many vaccines have been developed through a trial and error approach, with a large pool of candidates tested in vitro to screen for the most effective ones. This approach can be time-consuming, costly, and not always lead to the most effective vaccines.
Machine learning can address these problems and provide a number of other benefits complementary to traditional vaccine development methods.
"Together with ImmuneWatch we were able to assess vaccine-induced T-cell signatures in our unique longitudinal sample collection of cancer patients. Based on antibody titers, it has previously been shown that cancer patients induce a weaker response towards COVID19 vaccines. T-cell immunity in this context is far less characterized and understood. Thanks to the ImmuneWatch DETECT platform we were able to take a deep dive into the SARS-CoV-2-specific T-cell response of our cancer patient cohort. "
ImmuneWatch DETECT wins Machine Learning competition
We are excited to share our recent win in the IMMREP23 Kaggle competition focused on TCR (T-cell receptor) specificity prediction.
Read the articleOur offering
Make your vaccine design process more data-driven by implementing machine learning and approaches from reverse vaccinology.
Reverse vaccinology as a service
Reverse Vaccinology Whitepaper
Exploring the Efficiency of Reverse Vaccinology
With the impending threats of antibiotic- resistant bacterial infections and future pandemics, implementing a fast and scalable vaccine development process is more urgent than ever. Reverse vaccinology is a computational vaccine-target identification method with stark benefits over traditional vaccine development. With a highly efficient pipeline, this bioinformatic technique allows for faster, safer, and cheaper vaccine development. Find out more about reverse vaccinology in this white paper.
Our offering
For industry professionals we offer a tailored and feature-rich version of ImmuneWatch DETECT, designed to meet industry-specific needs. In addition, ImmuneWatch supports research and education. ImmuneWatch DETECT is therefore free to use for academics and non-profit organisations. This dual approach aims to advance both academic and professional pursuits in our field.